Brief: Biosergen Rights Issue Oversubscribed
28/08/2026 14:01
BRIEF-Biosergen Rights Issue Oversubscribed Aug 28 (Reuters) - Biosergen AB BIOSGN.ST:
BIOSERGEN'S RIGHTS ISSUE OVERSUBSCRIBED
RIGHTS ISSUE HAS BEEN OVERSUBSCRIBED BY APPROXIMATELY 152 PERCENT AND GUARANTEE COMMITMENTS WILL NOT BE UTILISED
WILL RECEIVE APPROXIMATELY SEK 39.9 MILLION BEFORE DEDUCTION OF TRANSACTION COSTS
Source text: ID:nWkr3skBRJ
Further company coverage: BIOSGN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Biosergen AB
See all newsBrief: Nasdaq Approves Biosergen's Delisting Application
Brief: Biosergen Applies For Delisting Of The Company's Shares From Nasdaq First North Growth Market Conditional Upon Completion Of The Merger With Flerie
Brief: Biosergen Resolves On Set-Off Issue
Brief: Biosergen Rights Issue Oversubscribed
Brief: Biosergen Reports H1 EBITDA Of SEK -10.5 Million